Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
$168M |
| 2 |
PACCAR
PCAR
|
$165M |
| 3 |
Exxon Mobil
XOM
|
$120M |
| 4 |
GE HealthCare
GEHC
|
$103M |
| 5 |
Visa
V
|
$96.1M |
Top Sells
| 1 |
Walmart
WMT
|
$331M |
| 2 |
JPMorgan Chase
JPM
|
$199M |
| 3 |
Thermo Fisher Scientific
TMO
|
$98.9M |
| 4 |
ConocoPhillips
COP
|
$80.4M |
| 5 |
NVIDIA
NVDA
|
$66.9M |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.08% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Relmada Therapeutics
RLMD
$47.1M
| $126K | ﹤0.01% |
55,568
-5,065
| -8% | -$11.4K |
|
|
PPTA
3277
Perpetua Resources
PPTA
$2.01B
| $124K | ﹤0.01% |
27,910
| – | – |
|
3278
Sypris Solutions
SYPR
$45.8M
| $124K | ﹤0.01% |
63,086
-11,784
| -16% | -$23.1K |
|
3279
BioAtla
BCAB
$26.3M
| $123K | ﹤0.01% |
45,991
+978
| +2% | +$2.62K |
|
|
TBLT
3280
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
| $120K | ﹤0.01% |
101,044
+85,843
| +565% | +$102K |
|
3281
Astrotech Corp
ASTC
$8.88M
| $120K | ﹤0.01% |
11,276
| – | – |
|
3282
Turkcell
TKC
$4.9B
| $120K | ﹤0.01% |
27,847
+3,016
| +12% | +$13K |
|
3283
Franklin Wireless
FKWL
$50.1M
| $117K | ﹤0.01% |
23,495
+12,702
| +118% | +$63.3K |
|
|
AEY
3284
DELISTED
ADDvantage Technologies Group, Inc.
AEY
| $115K | ﹤0.01% |
104,037
-1,320
| -1% | -$1.47K |
|
|
OMGA
3285
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $115K | ﹤0.01% |
19,126
| – | – |
|
3286
enVVeno Medical
NVNO
$15.6M
| $114K | ﹤0.01% |
24,004
+2,511
| +12% | +$11.9K |
|
3287
Applied Optoelectronics
AAOI
$1.46B
| $114K | ﹤0.01% |
51,364
-8,189
| -14% | -$18.1K |
|
3288
Veritone
VERI
$172M
| $112K | ﹤0.01% |
19,232
+991
| +5% | +$5.78K |
|
|
UBX
3289
DELISTED
Unity Biotechnology
UBX
| $111K | ﹤0.01% |
67,899
+37,473
| +123% | +$61.1K |
|
3290
Verrica Pharmaceuticals
VRCA
$50.5M
| $110K | ﹤0.01% |
+16,967
| New | +$110K |
|
3291
AC Immune
ACIU
$222M
| $108K | ﹤0.01% |
+46,247
| New | +$108K |
|
3292
Nortech Systems
NSYS
$25.2M
| $108K | ﹤0.01% |
10,138
+28
| +0.3% | +$298 |
|
|
BLPH
3293
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $107K | ﹤0.01% |
+13,585
| New | +$107K |
|
3294
AYTU BioPharma
AYTU
$21.1M
| $106K | ﹤0.01% |
+47,263
| New | +$106K |
|
|
DBTX
3295
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $105K | ﹤0.01% |
34,607
| – | – |
|
3296
Clover Health Investments
CLOV
$1.38B
| $104K | ﹤0.01% |
122,739
-50,446
| -29% | -$42.6K |
|
3297
Lyell Immunopharma
LYEL
$219M
| $101K | ﹤0.01% |
42,745
-91,849
| -68% | -$217K |
|
3298
Motorsport Games
MSGM
$14.9M
| $101K | ﹤0.01% |
+17,678
| New | +$101K |
|
3299
Carisma Therapeutics
CARM
$18.4M
| $101K | ﹤0.01% |
+32,448
| New | +$101K |
|
3300
INNOVATE Corp
VATE
$74.1M
| $101K | ﹤0.01% |
+33,853
| New | +$101K |
|